UTC Therapeutics Inc.

News release

2026-03-06

Breaking Through Solid Tumors: UTC Therapeutics’ CAR-T Clinical Data to Be Presented at AACR 2026

Two pivotal CAR-T research programs were selected for presentation at AACR 2026. The company will unveil groundbreaking clinical data on a global first-in-human basis through one oral presentation and one poster presentation.

Details

2021-12-25
Apart from involving in collab-oration with Novartis on the...

Is a bio-tech providing next-generation T-cell therapy to overcome TME challenges and it has raised over 200 million dollar from investors since

Details
2021-12-25
Founded in Octber of 2019 in Shanghai by ZHAO Yangbing

LIU Xiaojun, and SONG Xiaodong, an ex-Pfizer and ex-J&J executive, UTC therapeutics is a pre-clinical biotech focusing on adoptive

Details

目前在第2页, 共有2页, 共有8条记录第一页上一页 1 2 下一页最后一页 跳转到页

Breaking Through Solid Tumors: UTC Therapeutics’ CAR-T Clinical Data to Be Presented at AACR 2026

Apart from involving in collab-oration with Novartis on the...

Founded in Octber of 2019 in Shanghai by ZHAO Yangbing